GHIS
Global Health Innovation Solutions
From Innovation to Impact
Our Mission
To accelerate the development, adoption and equitable access to global health innovations through strategic insights and local intelligence
Our Vision
A world where transformative health technologies reach the people who need them most – quickly, sustainably, and at scale
Product, portfolio and market strategy to guide organisations toward high impact decisions.
Guidance through regulatory, procurement and partner landscapes.
Partnership building and opportunity shaping for sustainable growth.
Translating strategy into real world execution and country readiness.
Insights from users, providers and systems in diverse LMIC contexts.
In a post pandemic era, we guide companies on creating business positive biosecurity strategies
Our Story
Global Health Innovation Solutions is a specialised global health and implementation advisory group emerging from decades of collaborative work in the global health innovation environment. Formed by a group of senior bio and med tech leaders, GHIS builds on a strong foundation of experience in product strategy, market shaping, partnership development and health security.
The company is led by Ed Kelley, a recognised leader in global health systems, technology adoption, patient safety and emergency preparedness. He is supported by a multidisciplinary team with expertise that spans strategy development, user and market research, product development support and field intelligence.
Together, the team combines high level institutional experience with practical insights from real world global health settings. We support organisations at the forefront of global health innovation, providing strategic guidance across areas such as biosecurity, AMR, pandemic preparedness and product and portfolio development. Our work strengthens decision making, aligns innovations with real‑world system needs and accelerates pathways from early concepts to sustainable adoption.
Our team brings experience across diagnostics, vaccines, therapeutics, health security, AMR and market shaping, working with industry, research institutes, donors and governments to create practical, sustainable pathways from concept to adoption.
Our Team
Dr. Kelley has over 30 years experience working at the highest levels of large public and private sector organizations to bring programmatic and product innovation to front-line health service delivery. He has specialized in creating sustainable markets for products in emerging markets and is one of the world’s experts on national and global health data and analytics. In his role as CEO of GHIS, Ed provides the overall global strategic direction for the company and chairs the company’s Board of Advisors
Yaw Addai Brenyah is a global health and innovation professional with experience working across product development, market access, and health systems in low and middle-income countries. His work focuses on helping organisations translate technical innovation into scalable, sustainable solutions that reach patients.
Yaw has worked with governments, industry partners, and international organisations on initiatives spanning injectable technologies, diagnostics, and health system strengthening. He brings hands-on experience in user and market research, stakeholder engagement, and implementation strategy, with a strong emphasis on aligning public health priorities with commercial and operational realities.
UK Operations
Charlotte oversees the British operations of GHIS, guiding strategy and delivery across the organization's global health advisory portfolio. With a background spanning global health, biochemistry, and international development she brings a multidisciplinary systems-level perspective to innovation strategy, market readiness, and health systems alignment. Charlotte has experience across private, public, and non-profit sectors advising on market expansion, working across global health partnerships, and contributing to clinical research partnerships and programme delivery. She is driven by a long-standing interest in how science, policy, and commercial strategy intersect to deliver sustainable health impact.
Located at the centre
of two leading biotech hub cities
with partners around the world
Why Choose Us
Boutique support tailored to organisational needs.
High level expertise without large consultancy overhead.
Real world intelligence that reduces uncertainty and accelerates decision making.
From early strategy to implementation and scale.
The landscape of global health has changed
In an increasingly interconnected world, global health and security practices must evolve rapidly as emerging threats transcend borders and increasingly outpace our traditional response mechanisms. At the same time, deep changes in how global health is funded have left markets and innovation partners disconnected and under-resourced. Ensuring access to innovation and biosecurity simultaneously will require cross-country collaboration, data-driven decision making, and understanding for the diverse markets and health systems. GHIS acts as a trusted, end-to-end advisor helping organisations navigate uncertainty by bringing insight that bridges innovation, markets, and real-world health systems.
Our Work
Global Strategy
Texas Biomed has over 80 years of scientific health discoveries advancing diagnostics, vaccines and therapies. Based in San Antonio, Texas Biomed is the one of the only private, nonprofit disease research institutes in the world with high containment laboratories (BSL-4) and a state of the art, federally designated primate research center. GHIS is supporting Texas Biomed leadership by bringing strategic foresight, as well as market and ecosystem insights to re-envision the Institute’s global health strategy, strengthen their international portfolio, and advance their Global Health Symposium.
Biosecurity Strategy
HIPRA is a Girona, Spain-based biotechnological pharmaceutical company focused on prevention for animal and human health, with a broad range of highly innovative vaccines and an advanced diagnostic service. Leveraging HIPRAs manufacturing leadership and unique knowledge of zoonotic diseases, GHIS is working with company leadership to develop a strong, business-positive biosecurity strategy for the company.
Business Development
Calla Lily Clinical Care is a healthcare organisation dedicated to advancing women’s health through comprehensive, patient-centred clinical services. The organisation focuses on addressing unmet needs across women’s health, with an emphasis on accessible, evidence-based care, integrated clinical models, and improving outcomes for women across the life course. GHIS is supporting Calla Lily in its early business development phase by connecting the organisation with international donors, promoting partnerships and supporting initial growth for the organisation.
Ecosystem Navigation
Persown Connect is an US-based startup pioneering a transformative digital health platform to bring low-cost essential diagnostics to the billion families across the world that lack access to adequate health care. At the same time, Persown and GHIS are upskilling community health workers in a financially sustainable way to bring care to where people live and work. GHIS is working with the Persown Connect team on partnership development, early stage funding and providing guidance on the company’s initial roll out in Tanzania, Ghana and Brazil.
